DocWire News Editors

DocwireNews

The diagnosis of growth hormone deficiency (GHD) by stimulation tests relies on measurement of growth hormone (GH) secretion, but there are several challenges to associated with the GH secretion test.&nbsp;Furthermore, the GH secretion test may be influenced by factors such obesity, undernutrition, sex, age, puberty, and presence of chronic diseases. It also has potential adverse reactions and may sometimes result in hospitalization. Therefore, a predictive biomarker for GHD is desired to avoid unnecessary GH secretion test.&nbsp;Previous research has suggested that insulin-like growth factor-1 (IGF-1), a small polypeptide hormone secreted by the liver when stimulated by GH, may be a potential biomarker for GHD, which was the focus of a recent study published in Scientific Reports by Hideyuki Iwayama and colleagues.&nbsp;&nbsp;The study authors evaluated the diagnostic accuracy of IGF-1 for screening GHD in a group of 298 consecutive children who had short stature or decreased height velocity. Children with congenital abnormalities were excluded from the study.Investigators measured IGF-1 levels and performed GH secretion testing using clonidine, arginine, and, in cases with different results of the two tests, L-dopa. GHD was defined as peak GH&thinsp;&le; 6.0&nbsp;ng/mL in the two tests.&nbsp;Overall, 60 patients were found to have GHD, and 238 patients did not have GHD. The researchers observed that mean IGF-1 standard deviation was not significantly different between the GHD and non-GHD groups (p=0.23). Receiver operating characteristic curve analysis demonstrated the best diagnostic accuracy at an IGF-1 cutoff of&thinsp;&minus;1.493 SD, with 0.685 sensitivity, 0.417 specificity, 0.25 positive and 0.823 negative predictive values, and 0.517 area under the curve.&nbsp;Correlation analysis revealed that no specific patient characteristic increased the diagnostic power of IGF-1, the authors reported. Overall, &ldquo;IGF-1 level had poor diagnostic accuracy as a screening test for GHD,&rdquo; they concluded. &ldquo;Therefore, IGF-1 should not be used alone for GHD screening. A predictive biomarker for GHD should be developed in the future.&rdquo;

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Insulin-Like Growth Factor-1 Level Is Poor Predictive Biomarker of GHD

Growth Hormone Deficiency

The diagnosis of growth hormone deficiency (GHD) by stimulation tests relies on measurement of growth hormone (GH) secretion, but there are several challenges to associated ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe